Indaptus Therapeutics, Inc. Share Price & Technical Analysis
INDP · $1.22 (+15.09%)
Healthcare / Biotechnology
$1.22
+15.09%
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and hu…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-57% return in May, -21% avg return in past 3 year May month.
-40% return in 2026, -54% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -24% | 0% | -14% | 56% | -57% | – | – | – | – | – | – | – | -40% |
| 25 | 11% | -6% | -36% | -15% | -31% | 17% | -14% | -20% | -54% | 10% | -31% | 32% | -136% |
| 24 | -8% | 33% | 2% | -8% | 5% | -19% | -11% | -18% | -25% | -5% | -11% | -22% | -89% |
| 23 | 22% | -1% | 7% | 39% | -36% | 10% | 21% | 43% | -7% | -11% | -2% | -23% | 62% |
| 22 | -13% | -19% | -4% | -27% | -19% | 6% | 4% | -10% | -10% | -20% | -9% | -20% | -140% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.11M
P/E ratio
—
52W high
$19.91
52W low
$0.92
Volume
1,99,793
Beta
1.39
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Indaptus Therapeutics, Inc. share price today?
- Indaptus Therapeutics, Inc. (INDP) last traded around $1.22 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does INDP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for INDP. Download the app for real-time alerts.
- How can I analyze Indaptus Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.